Turning Innovation into Investment: A Conversation with Anne Mazet

At conferences like BIO, breakthrough science commands the spotlight. But behind every successful healthcare company is another story; one of founders, investors, mentors, and the difficult journey from promising research to investable business.

In this episode of The Commons, host Thomas Osha welcomes Anne Mazet, Chief-of-Staff at Xcellerant Ventures, for a candid conversation about what separates great science from companies capable of attracting investment and creating lasting impact.

Anne shares why venture investors often place as much emphasis on founders as they do on technology, why researchers should engage investors earlier than they think, and how coachability, strategic planning, and the willingness to build the right leadership team can dramatically improve a company's odds of success.

The discussion also explores Phoenix's collaborative innovation ecosystem, the evolving venture capital landscape, and Xcellerant's innovative Jetstream Venture Fund, which is expanding access to venture investing through a more inclusive investment model. Along the way, Anne offers practical advice for university spinouts, startup founders, and anyone navigating the challenging path from laboratory discovery to commercialization.

Whether you're building a startup, supporting technology transfer, or simply curious about how healthcare innovation reaches the marketplace, this episode provides valuable insights into the people, partnerships, and investment decisions that turn promising ideas into successful companies.